Canadian Telemedicine Provider, Wello, Launches COVID-19 Return to Workplace Platform for Employers

Daily risk screening protocol, integrated clinical support and data management capabilities prioritize safety when transitioning employees back into public spaces.

TORONTO, July 13, 2020 /CNW/ – As the Canadian economy continues reopening amidst COVID-19, businesses face many new challenges and considerations in safely welcoming their employees back to their physical workplace. Many employees also have concerns about returning to their workplaces while keeping themselves, their families, and their coworkers safe and healthy.  

In response to client requests for expanded support, Canadian telemedicine provider, Wello, has developed an integrated self-screening & reporting protocol to help manage the risk of bringing COVID-19 into the workplace. Return to Workplace is an online tool that provides companies with accurate, real–time data on the eligibility of their workforce to return to the physical workplace safely. While businesses are not able to fully mitigate the risk of COVID-19 in workplaces, business leaders who require employees to be physically present are given confidence that employees are being supported and directed in taking the necessary steps to provide a protected space.

In alignment with all Canadian provincial and territorial public health guidelines, employees answer a three–part questionnaire in the tool to determine any presence of health risk. If an employee is not eligible to return, they are provided with access to clinical guidance on appropriate next steps and offered the necessary follow-up support to navigate what may feel like a daunting process.

“Businesses can play a role in reducing the spread of COVID-19 by conducting daily fit-for-work screening of employees before entering their physical workplaces. This simple strategy can make a difference and give employees and customers reassurance and confidence that their health and safety is valued and protected,” said Dr. Wendy Smeltzer, National Medical Director, Wello.

As we all remain focused on minimizing the spread of the coronavirus, diligent screening, risk management and mental well-being are top priorities. The Return to Workplace platform offers important resources for both employers and employees so that everyone can feel safer and more secure when they must be in a physical work environment. The new platform is now available to all Canadian employers. For more information please visit, https://wello.ca/return-to-the-workplace or contact Randy Wetmore wetmorer@wello.ca.

ABOUT WELLO
Wello is a leading Canadian provider of anytime, anywhere virtual healthcare services. Wello healthcare services are available through phone and video visits as well as secure webchat. Backed by a 41–year history of providing high–quality healthcare through its parent company, INLIV, Wello can be offered as part of a company’s health benefits for its employees.

SOURCE Wello

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago